Pasteurella haemolytica Vaccines and Their Effectiveness
DOI:
https://doi.org/10.21423/aabppro19956162Keywords:
Pasteurella haemolytica, immune response, Bacterin-toxoid vaccine, inoculation, formulations, intramuscular, subcutaneousAbstract
Pasteurella haemolytica biotype A, serotype 1 (Ph1) bacterins and bacterin-toxoids formulated in oil adjuvants induce protective immune responses approaching those induced by virulent Ph1. In comparison, aluminum hydroxide based adjuvants induce lower protective and serological immune responses. Bacterin-toxoid vaccines formulated in water-in-oil adjuvants induced high levels of protective immunity against transthoracic and field challenge. Bacterin-toxoid with oil-in-water adjuvant induced high protective immunity against transthoracic challenge and was superior to Ph1 bacterin-toxoid withAI(OH)3 adjuvant. Reactions at the point of inoculation vary with formulations, are usually inapparent if intramuscular, manageable if subcutaneous and disappear with time.